Urinary prostate specific antigen levels: Role in monitoring the response of prostate cancer to therapy

Ralph W deVere White, Frederick J Meyers, S. E. Soares, D. G. Miller, T. F. Soriano

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

We have shown that prostate specific antigen (PSA) levels can be as readily obtained from voided urine as from serum samples. This procedure was found to give stable and reproducible results. PSA analyses were performed on voided urine collected from 42 patients with benign prostatic hypertrophy (BPH), 27 with stage D2 prostate cancer and 57 after radical prostatectomy. The 42 BPH samples had a mean urinary PSA level of 216 ng./ml., which did not correlate with estimated prostate size. For 4 of 5 patients with stage D2 disease who presented before hormonal therapy urinary PSA levels were greater than 50 ng./ml. For 22 stage D2 patients seen after initiation of hormonal therapy the majority had low urinary PSA levels. After initiation of hormonal therapy in most cases low urinary PSA levels were found in conjunction with high serum PSA values. However, in other cases we found high urinary PSA with low serum PSA levels. Of 43 patients who underwent radical prostatectomy for stages A to C disease it was noteworthy that 77% had elevated urinary PSA levels, while only 33% had elevated serum levels. Therefore, close to 80% of these patients have prostate tissue remaining locally after this operation.

Original languageEnglish (US)
Pages (from-to)947-951
Number of pages5
JournalJournal of Urology
Volume147
Issue number3 II
StatePublished - 1992

Fingerprint

Prostate-Specific Antigen
Prostatic Neoplasms
Therapeutics
Prostatic Hyperplasia
Prostatectomy
Serum
Prostate
Urine

Keywords

  • antigens, differentiation
  • hormone antagonists
  • prostatectomy
  • prostatic hypertrophy
  • prostatic neoplasms

ASJC Scopus subject areas

  • Urology

Cite this

Urinary prostate specific antigen levels : Role in monitoring the response of prostate cancer to therapy. / deVere White, Ralph W; Meyers, Frederick J; Soares, S. E.; Miller, D. G.; Soriano, T. F.

In: Journal of Urology, Vol. 147, No. 3 II, 1992, p. 947-951.

Research output: Contribution to journalArticle

@article{07aaed04d26c42a8ad1ec8dadffcbb7d,
title = "Urinary prostate specific antigen levels: Role in monitoring the response of prostate cancer to therapy",
abstract = "We have shown that prostate specific antigen (PSA) levels can be as readily obtained from voided urine as from serum samples. This procedure was found to give stable and reproducible results. PSA analyses were performed on voided urine collected from 42 patients with benign prostatic hypertrophy (BPH), 27 with stage D2 prostate cancer and 57 after radical prostatectomy. The 42 BPH samples had a mean urinary PSA level of 216 ng./ml., which did not correlate with estimated prostate size. For 4 of 5 patients with stage D2 disease who presented before hormonal therapy urinary PSA levels were greater than 50 ng./ml. For 22 stage D2 patients seen after initiation of hormonal therapy the majority had low urinary PSA levels. After initiation of hormonal therapy in most cases low urinary PSA levels were found in conjunction with high serum PSA values. However, in other cases we found high urinary PSA with low serum PSA levels. Of 43 patients who underwent radical prostatectomy for stages A to C disease it was noteworthy that 77{\%} had elevated urinary PSA levels, while only 33{\%} had elevated serum levels. Therefore, close to 80{\%} of these patients have prostate tissue remaining locally after this operation.",
keywords = "antigens, differentiation, hormone antagonists, prostatectomy, prostatic hypertrophy, prostatic neoplasms",
author = "{deVere White}, {Ralph W} and Meyers, {Frederick J} and Soares, {S. E.} and Miller, {D. G.} and Soriano, {T. F.}",
year = "1992",
language = "English (US)",
volume = "147",
pages = "947--951",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "3 II",

}

TY - JOUR

T1 - Urinary prostate specific antigen levels

T2 - Role in monitoring the response of prostate cancer to therapy

AU - deVere White, Ralph W

AU - Meyers, Frederick J

AU - Soares, S. E.

AU - Miller, D. G.

AU - Soriano, T. F.

PY - 1992

Y1 - 1992

N2 - We have shown that prostate specific antigen (PSA) levels can be as readily obtained from voided urine as from serum samples. This procedure was found to give stable and reproducible results. PSA analyses were performed on voided urine collected from 42 patients with benign prostatic hypertrophy (BPH), 27 with stage D2 prostate cancer and 57 after radical prostatectomy. The 42 BPH samples had a mean urinary PSA level of 216 ng./ml., which did not correlate with estimated prostate size. For 4 of 5 patients with stage D2 disease who presented before hormonal therapy urinary PSA levels were greater than 50 ng./ml. For 22 stage D2 patients seen after initiation of hormonal therapy the majority had low urinary PSA levels. After initiation of hormonal therapy in most cases low urinary PSA levels were found in conjunction with high serum PSA values. However, in other cases we found high urinary PSA with low serum PSA levels. Of 43 patients who underwent radical prostatectomy for stages A to C disease it was noteworthy that 77% had elevated urinary PSA levels, while only 33% had elevated serum levels. Therefore, close to 80% of these patients have prostate tissue remaining locally after this operation.

AB - We have shown that prostate specific antigen (PSA) levels can be as readily obtained from voided urine as from serum samples. This procedure was found to give stable and reproducible results. PSA analyses were performed on voided urine collected from 42 patients with benign prostatic hypertrophy (BPH), 27 with stage D2 prostate cancer and 57 after radical prostatectomy. The 42 BPH samples had a mean urinary PSA level of 216 ng./ml., which did not correlate with estimated prostate size. For 4 of 5 patients with stage D2 disease who presented before hormonal therapy urinary PSA levels were greater than 50 ng./ml. For 22 stage D2 patients seen after initiation of hormonal therapy the majority had low urinary PSA levels. After initiation of hormonal therapy in most cases low urinary PSA levels were found in conjunction with high serum PSA values. However, in other cases we found high urinary PSA with low serum PSA levels. Of 43 patients who underwent radical prostatectomy for stages A to C disease it was noteworthy that 77% had elevated urinary PSA levels, while only 33% had elevated serum levels. Therefore, close to 80% of these patients have prostate tissue remaining locally after this operation.

KW - antigens, differentiation

KW - hormone antagonists

KW - prostatectomy

KW - prostatic hypertrophy

KW - prostatic neoplasms

UR - http://www.scopus.com/inward/record.url?scp=0026569058&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026569058&partnerID=8YFLogxK

M3 - Article

C2 - 1371566

AN - SCOPUS:0026569058

VL - 147

SP - 947

EP - 951

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 3 II

ER -